Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
Clinical trial NCT03166215 · COMPLETED
Trial details
- NCT number
- NCT03166215
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-17
- Primary completion
- 2018-09-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.